| 产品名称: | Cedecea lapagei Grimont et al. |
|---|---|
| 商品货号: | TS142401 |
| Strain Designations: | CDC 0485-76 CIP 80.35, P.A.D. Grimont 004 |
| Isolation: | Human throat, Canada |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | Freeze-Dried: 2°C to 8°C |
| Preceptrol®: | no |
| Type Strain: | yes (type strain) |
| Medium: | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions: | Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor: | CDC |
| Chain of Custody: | ATCC <-- CDC <-- Canadian CDC |
| References: | Grimont PA, et al. Cedecea davisae gen. nov., sp. nov. and Cedecea lapagei sp. nov., new Enterobacteriaceae from clinical specimens. Int. J. Syst. Bacteriol. 31: 317-326, 1981. type strain type strain |
| Cross References: | Nucleotide (GenBank) : AX109524 Sequence 257 from Patent WO0123604. |